LifeWatch has filed to come public in an IPO via a sale of up to $86.25 million in common stock. It even has the proposed ticker "LIFE" on NASDAQ. The company has listed Jefferies & Co., Cowen & Co. and Piper Jaffray as the joint bookrunners.
The company claims to be the leading independent provider of ambulatory cardiac event monitoring services and the leading manufacturer and distributor of ambulatory cardiac event monitoring devices; and claims this is a $1.1 billion industry according to the 2004 Frost & Sullivan study. On August 23, 2006, the FDA approved for marketing the LifeStar ACT™ and it has the exclusive right to offer services using the LifeStar ACT™ in the United States through 2011 and are in the process of launching. 2005 revenues were $37.5M and it posted a $7.8M net income after some tax benefits. Its sales for the first 9-months of 2006 were $31 million with net income of $1.2 million after a $1.3 million tax loss.
This appears is the US operation backed by Card Guard AG, a public company in Switzerland (was previously and improperly listed as Life Guard in Germany, which was an error).
Jon C. Ogg
December 13, 2006